Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,118 | 49,046 | 111,471 | 215,507 | 244,979 |
| TOTAL | $8,013 | $51,232 | $116,406 | $220,431 | $247,292 |
| Non-Current Assets | |||||
| PPE Net | 120 | 678 | 1,603 | 2,728 | 3,676 |
| Other Non-Current Assets | 5,695 | 512 | 1,649 | 2,577 | 3,454 |
| TOTAL | $5,815 | $1,190 | $3,252 | $5,305 | $7,130 |
| Total Assets | $13,828 | $52,422 | $119,658 | $225,736 | $254,422 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,353 | 13,704 | 26,720 | 21,610 | 18,424 |
| Other current liabilities | 4,142 | N/A | N/A | N/A | N/A |
| TOTAL | $21,922 | $14,540 | $28,344 | $23,131 | $19,813 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 28,095 | 23,617 | 20,642 | 22,266 | 23,788 |
| TOTAL | $28,095 | $23,617 | $20,642 | $22,266 | $23,788 |
| Total Liabilities | $50,017 | $38,157 | $48,986 | $45,397 | $43,601 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,846 | 58,401 | 48,097 | 47,607 | 37,321 |
| Common Shares | 6 | 6 | 5 | 5 | 4 |
| Retained earnings | -545,646 | -486,039 | -416,263 | -292,801 | -186,319 |
| TOTAL | $-36,189 | $14,265 | $70,672 | $180,339 | $210,821 |
| Total Liabilities And Equity | $13,828 | $52,422 | $119,658 | $225,736 | $254,422 |